[1]
“Optimization of an HPLC-PDA analytical method for therapeutic monitoring of oral busulfan in hematopoietic stem cell transplant patients”, RSD, vol. 10, no. 6, p. e48110615864, Jun. 2021, doi: 10.33448/rsd-v10i6.15864.